Welcome Annie Bernier.

CQDM. We grow.CQDM is proud to announce the addition of a new member to its team! Welcome to Annie Bernier who joins as Project Manager, Scientific Affairs.Before joining the team, Annie spent over 2 years in Paris where she worked as a laboratory manager at the Institut Curie, a cancer research and treatment center. Her…

Predict lung cancer risk.

CQDM. We do it. During the lung cancer awareness month, CQDM is proud to announce its participation in this project to predict lung cancer risk. The research project of the team of Philippe Joubert and Yohan Bossé of the Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval consist on the development…

Welcome Catherine-Alexandra.

CQDM. We grow.CQDM is proud to announce the addition of a new member to its team! Welcome to Catherine-Alexandra Grégoire, Ph.D, CRP who joins as Project Manager, Scientific Affairs.Before joining the team, she held the position of research associate at the EPIC Centre of the Montreal Heart Institute. Her research focused on the impact of…

New partnership with Axelys.

CQDM. We collaborate. CQDM is proud to announce a new collaboration / broadcast / communication partnership with Axelys. This new partnership will allow greater reach to facilitate biopharma innovation in the Quebec ecosystem and beyond. Axelys is the Quebec organization for development and transfer of high-potential innovations stemming from public research. It contributes to the…

15th of CQDM.

CQDM. We celebrate. CQDM celebrates its 15th anniversary. We have some great dates and milestones to highlight and share with you. We start with 2008, the year of the foundation of CQDM. In 2008, the Quebec consortium for drug discovery (CQDM) is founded by Max Fehlmann, with the support and backing of the Fonds de Recherche en…

Congratulations Alexandre Morizot.

CQDM. We grow.CQDM is proud to announce the internal promotion of Alexandre Morizot as Director of Business Development. In this new role, Alexandre’s mandate is to create links between companies and university researchers to facilitate and propel collaborative research projects resulting in biopharmaceutical innovations. Along with the CQDM team, he is also actively involved in…

New partnership with IVADO.

CQDM. We collaborate.CQDM is proud to announce a new collaboration / diffusion / communication partnership with IVADO.We are confident that this new partnership will facilitate biopharma innovation in the Quebec ecosystem and beyond, with a collaborator strongly involved in a complementary sector.IVADO is an interdisciplinary, cross-sectoral research, training and knowledge mobilization consortium whose mission is…

Scientific days of the CRCHUM.

CQDM. We share.The management of the Centre de recherche du CHUM (CRCHUM) invites you to participate in the 14th scientific days which will be held on October 25 and 26, 2023.As part of this unique event, renowned speakers will reveal their most recent scientific advances and their impact on population health.Véronique Dugas, Ph.D., MBA from…

Success of a preclinical study against breast cancer.

CQDM. We do it.During the breast cancer awareness month, CQDM is proud to announce its participation in the clinical design project for a new targeted and personalized treatment against Sortilin-positive triple negative breast cancers.The research team of Dr. Borhane Annabi at the UQAM | Université du Québec à Montréal, in collaboration with the Theratechnologies Inc.…

Appointments to the CQDM Board of Directors.

Press release:  Carole Jabet, Steven Klein and Daria Riabinina join CQDM’s board of directors. MONTREAL, October 11, 2023 – CQDM is proud to announce the appointment of Carole Jabet, Scientific Director at the Fonds de Recherche du Québec en Santé (FRQ-S) and Steven Klein, Chief Business Officer at Epitopea, to its board of directors. Also,…